摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one | 96930-16-4

中文名称
——
中文别名
——
英文名称
(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one
英文别名
(4R,5S)-4-methyl-5-phenyl-3-(2-phenylacetyl)-1,3-oxazolidin-2-one
(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one化学式
CAS
96930-16-4
化学式
C18H17NO3
mdl
——
分子量
295.338
InChiKey
FJKWWFGNYPFCTF-CXAGYDPISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    488.1±44.0 °C(Predicted)
  • 密度:
    1.213±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one 在 Schwartz's reagent 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 以51%的产率得到苯乙醛
    参考文献:
    名称:
    Mild and Selective Hydrozirconation of Amides to Aldehydes Using Cp2Zr(H)Cl:  Scope and Mechanistic Insight
    摘要:
    An investigation of the use of Cp2Zr(H)Cl (Schwartz's reagent) to reduce a variety of amides to the corresponding aldehydes under very mild reaction conditions and in high yields is reported. A range of tertiary amides, including Weinreb's amides, can be converted directly to the corresponding aldehydes with remarkable chemoselectivity. Primary and secondary amides proved to be viable substrates for reduction as well, although the yields were somewhat diminished as compared to the corresponding tertiary amides. Results from NMR experiments suggested the presence of a stable, 18-electron zirconacycle intermediate that presumably affords the aldehyde upon water or silica gel workup. A series of competition experiments revealed a preference of the reagent for substrates in which the lone pair of the nitrogen is electron releasing and thus more delocalized across the amide bond by resonance. This trend accounts for the observed excellent selectivity for tertiary amides versus esters. Experiments regarding the solvent dependence of the reaction suggested a kinetic profile similar to that postulated for the hydrozirconation of alkenes and alkynes. Addition of p-anisidine to the reaction intermediate resulted in the formation of the corresponding imine mimicking the addition of water that forms the aldehyde.
    DOI:
    10.1021/ja066362+
  • 作为产物:
    描述:
    参考文献:
    名称:
    WO2007/41366
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Asymmetric synthesis of optically active 2,3-diarylsuccinic acids by oxidative homocoupling of chiral 3-(arylacetyl)-2-oxazolidones
    作者:Naoki Kise、Kimikage Kumada、Yuichi Terao、Nasuo Ueda
    DOI:10.1016/s0040-4020(98)83006-8
    日期:1998.3
    Oxidative homocoupling of chiral 3-(arylacetyl)-2-oxazolidones 1 was achieved by treatment with DABCO-TiCl4 or DMAP-TiCl4 and afforded the corresponding dimers stereospecifically. The reaction of (4S)- and (4R)-substituted 1 gave (S,S)- and (R,R)-dimers respectively. The obtained dimers were easily transformed to the corresponding 2,3-diaryl succinic acids. This reaction therefore provides a useful
    通过用DABCO-TiCl 4或DMAP-TiCl 4处理,实现手性3-(芳基乙酰基)-2-恶唑烷酮1的氧化均偶联,并立体定向提供相应的二聚体。(4S)-和(4R)-取代的1的反应得到(S,S)-和(R,R)-二聚体。获得的二聚体容易转化为相应的2,3-二芳基琥珀酸。因此,该反应提供了用于合成光学纯的2,3-二芳基琥珀酸的有用方法。芳基上的给电子基团的对位取代不会抑制氧化偶合。然而,对位取代的吸电子基团和邻位取代基阻碍了偶联。
  • Enantioselective synthesis of 2-substituted 3-aminopropanoic acid (β-alanine) derivatives which are β-analogues of aromatic amino acids
    作者:Elena Arvanitis、Holger Ernst、Alice A. LudwigéD’Souza、Andrew J. Robinson、Peter B. Wyatt
    DOI:10.1039/a706163c
    日期:——
    3-Aminopropanoic acid derivatives with a phenyl, 4-hydroxyphenyl, benzyl or indol-3-yl substituent at C-2 can be prepared enantioselectively by routes involving electrophilic attack of synthetic equivalents of [H2NCH2]+ upon enolates derived from chiral 3-acyl-1,3-oxazolidin-2-ones. tert-Butyl bromoacetate may be used as the electrophile, with subsequent introduction of nitrogen through the Curtius reaction, using the sequence of reagents (i) CF3CO2H; (ii) (PhO)2P(O)N3, Et3N, PhCH2OH; alternatively, direct electrophilic reaction with 1-[N-(benzyloxycarbonyl)aminomethyl]benzotriazole 4c or benzyl N-(acetoxymethyl)carbamate 2d introduces a protected aminomethyl group in a single step.
    具有苯基、4-羟基苯基、苄基或吲哚-3-基的C-2取代基的3-氨基丙酸衍生物可以通过涉及合成[H2NCH2]+的亲电攻击的路线,从手性3-酰基-1,3-恶唑烷-2-酮衍生的烯醇盐选择性地制备。可以使用叔丁基溴乙酸酯作为亲电试剂,随后通过Curtius反应引入氮,使用试剂序列(i)CF3CO2H;(ii)(PhO)2P(O)N3,Et3N,PhCH2OH;或者,直接与1-[N-(苄氧羰基)氨基甲基]苯并三唑4c或苄基N-(乙酸甲酯)氨基甲酸酯2d进行亲电反应,一步引入保护的氨基甲基基团。
  • Asymmetric synthesis of α-fluoro ketones using α-fluoro oxazolidinone carboximides
    作者:Franklin A. Davis、Parimala V.N. Kasu
    DOI:10.1016/s0040-4039(98)01296-9
    日期:1998.8
    Addition of Grignard reagents to enantiopure α-fluoro N-methoxy-N-methylamides 5 affords α-fluoro ketones (R)-6 in >96% ee.
    向对映体纯的α-氟代N-甲氧基-N-甲基酰胺5中添加格氏试剂可得到> 96%ee的α-氟代酮(R)-6。
  • Organic Compounds
    申请人:Bebernitz Gregory Raymond
    公开号:US20080312256A1
    公开(公告)日:2008-12-18
    The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, type 2 diabetes and obesity.
    本发明提供了以下式子的化合物,它们是葡萄糖激酶活性的激活剂,因此可以作为治疗葡萄糖激酶介导疾病的治疗剂。因此,式(I)的化合物可用于预防和治疗糖耐量受损、2型糖尿病和肥胖症。
  • Thiazolo[5,4-B]pyridine glucokinase activators
    申请人:Novartis AG
    公开号:US08252931B2
    公开(公告)日:2012-08-28
    The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, type 2 diabetes and obesity.
    本发明提供了式子(I)的化合物,它们是葡萄糖激酶活性的激活剂,因此可以作为治疗葡萄糖激酶介导疾病的治疗剂。因此,式(I)的化合物可用于预防和治疗糖耐量受损、2型糖尿病和肥胖症。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐